US Stock MarketDetailed Quotes

PXMD PaxMedica

Watchlist
  • 0.535
  • +0.024+4.74%
Close Mar 27 16:00 ET
3.96MMarket Cap-48P/E (TTM)

About PaxMedica Company

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.

Company Profile

SymbolPXMD
Company NamePaxMedica
Listing Date08/26/2022
Issue Price5.25
Founded2018
CEOMr. Howard J. Weisman
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address303 South Broadway,Suite 125
CityTarrytown
ProvinceNew York
CountryUnited States of America
Zip Code10591
Phone1-914-987-2876

Company Executives

  • Name
  • Position
  • Salary
  • Howard J. Weisman
  • Chief Executive Officer and Chairman of the Board
  • 4.01M
  • Dr. David Hough, M.D.
  • Chief Medical Officer
  • 327.50K
  • Stephen D. Sheldon
  • Chief Financial Officer, Principal Accounting Officer and Chief Operating Officer
  • 501.63K
  • Zachary Rome
  • Director
  • --
  • Charles J. Casamento
  • Lead Independent Director
  • 138.30K
  • Karen LaRochelle
  • Independent Director
  • 315.81K
  • John F. Coelho
  • Independent Director
  • 292.69K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg